CAPTRUST Financial Advisors’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3
| Closed | -$1K | – | 4941 |
|
|
2022
Q1 | $1K | Buy |
3
+2
| +200% | +$667 | ﹤0.01% | 4660 |
|
|
2021
Q4 | $0 | Sell |
1
-16
| -94% | – | ﹤0.01% | 4769 |
|
|
2021
Q3 | $8K | Hold |
17
| – | – | ﹤0.01% | 3721 |
|
|
2021
Q2 | $8K | Sell |
17
-1
| -6% | -$471 | ﹤0.01% | 3650 |
|
|
2021
Q1 | $12K | Sell |
18
-176
| -91% | -$117K | ﹤0.01% | 3327 |
|
|
2020
Q4 | $143K | Hold |
194
| – | – | ﹤0.01% | 1341 |
|
|
2020
Q3 | $139K | Buy |
194
+178
| +1,113% | +$128K | ﹤0.01% | 1197 |
|
|
2020
Q2 | $13K | Buy |
+16
| New | +$13K | ﹤0.01% | 2090 |
|